Role of endothelial nitric oxide synthase in endothelial cell migration

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1156-1161

  Murohara, Toyoaki ^a,b   Witzenbichler, Bernhard ^a   Spyridopoulos, Ioakim ^a   Asahara, Takayuki ^a   Ding, Bo ^a   Sullivan, Alison ^a   Losordo, Douglas W ^a   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Cell adhesion molecule; Endothelial migration; Endothelium derived relaxing factor

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DNA SYNTHESIS INHIBITION; ENANTIOMER; ENDOTHELIUM CELL; ENZYME REGULATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

EID: 0032949776     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1156     Document Type: Article

References (35)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-30.
2. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzzi CA, Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am J Pathol. 1996;149:293-305.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
4. Sun C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato T, Yancopoulos GD. Requisite role of angiopoetin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171-1180.
5. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin alpha-v-beta-3 for angiogenesis. Science. 1994;264:569-571.
6. Brooks PC, Montgomery AMP, Rossenfeld M, Reisfeld RA, Hu T, Killer G, Cheresh DA. Integrin alpha-v-beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994; 79:1157-1164.
7. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest. 1996;98: 1949-1953.
8. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
10. Radomski MW, Palmer RMJ, Moncada S. An L-arginine /nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 1990;87:5193-5197.
11. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte-adhesion. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
12. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
13. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
14. Janicek MJ, Meyerovitz M, Harrington DP, Hollenberg NK. Arterial response to ketanserin and aspirin in patients with advanced peripheral atherosclerosis. Invest Radiol. 1992;27:415-421.
15. Guo J-P, Murohara T, Panday MM, Lefer AM. Nitric oxide promotes endothelial cell proliferation: role in inhibiting restenosis. Circulation. 1996;92:I-750. Abstract.
16. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-H592.
17. van der Zee R, Murohara T, Luo Z, Zollmann F, Passen J, Lekutat C, Isner JM. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997;95:1030-1037.
18. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1995;270:H411-H415.
19. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
20. WAF1CIP1 expression by vascular cell integrin alpha-v-beta-3 during angiogenesis. J Clin Invest. 1996;98:426-433.
21. Weyrich AS, Ma X-1, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75:692-700.
22. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest. 1996;97:469-476.
23. Saffitz JE, Sullivan A, Isner JM. Regulation of endothelial cell connexin expression by vascular endothelial growth factor. Circulation. 1996;94: I-238. Abstract.
24. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest. 1994;94:2036-2044.
25. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
26. 165. Lancet. 1996;348: 370-374.
27. Murohara T, Horowitz JR, Silver M, Tsummi Y, Sullivan A, Isner JM. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998; 97:99-107.
28. Pipili-Synetos E, Sakkoula E, Maragoudakis ME. Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol. 1993;108:855-857.
29. Spyridopoulos I, Murohara T, Ding B, Principe NM, Sullivan AS, Losordo DW. VEGF inhibits human endothelial cell apoptosis induced by growth factor withdrawal and preserves functional activity. Circulation. 1997;96:1-419. Abstract.
30. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995;376:517-519.
31. DeCaterina R, Libby P, Peng H-B, Thannickol VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
32. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:9114-9119.
33. Okada Y, Copeland BR, Hamann GF, Koziol JA, Cheresh DA, del Zoppo GJ. Integrin is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol. 1996;149:37-44.
34. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95: 2068-2074.
35. Bode-Boger SM, Boger RH, Thiele W, Creutzig A, Alexander K, Frolich JC. L-Arginine infusion therapy restores vascular NO production and improves the symptoms of intermittent claudication in patients with peripheral arterial disease. Circulation. 1997;96:I-419. Abstract.